Novavax Debt

NVAX Stock  USD 8.04  0.02  0.25%   
Novavax has over 229.08 Million in debt which may indicate that it relies heavily on debt financing. At this time, Novavax's Short and Long Term Debt is fairly stable compared to the past year. Net Debt To EBITDA is likely to rise to 0.73 in 2024, despite the fact that Net Debt is likely to grow to (322.5 M). With a high degree of financial leverage come high-interest payments, which usually reduce Novavax's Earnings Per Share (EPS).

Asset vs Debt

Equity vs Debt

Novavax's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Novavax's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Novavax Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Novavax's stakeholders.
For most companies, including Novavax, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Novavax, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Novavax's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
49.522
Book Value
(3.29)
Operating Margin
(1.54)
Profit Margin
(0.32)
Return On Assets
(0.11)
Given that Novavax's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Novavax is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Novavax to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Novavax is said to be less leveraged. If creditors hold a majority of Novavax's assets, the Company is said to be highly leveraged.
At this time, Novavax's Total Current Liabilities is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 1.9 B in 2024, despite the fact that Change To Liabilities is likely to grow to (144.8 M).
  
Check out the analysis of Novavax Fundamentals Over Time.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

Novavax Bond Ratings

Novavax financial ratings play a critical role in determining how much Novavax have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Novavax's borrowing costs.
Piotroski F Score
3
FrailView
Beneish M Score
(2.08)
Possible ManipulatorView

Novavax Debt to Cash Allocation

As Novavax follows its natural business cycle, the capital allocation decisions will not magically go away. Novavax's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Novavax currently holds 229.08 M in liabilities with Debt to Equity (D/E) ratio of 8.24, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Novavax has a current ratio of 1.03, suggesting that it may not be capable to disburse its financial obligations when due. Note, when we think about Novavax's use of debt, we should always consider it together with its cash and equity.

Novavax Total Assets Over Time

Novavax Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Novavax uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Novavax Debt Ratio

    
  8.88   
It appears most of the Novavax's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Novavax's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Novavax, which in turn will lower the firm's financial flexibility.

Novavax Corporate Bonds Issued

Novavax Net Debt

Net Debt

(322.45 Million)

Novavax reported Net Debt of (339.42 Million) in 2023

Understaning Novavax Use of Financial Leverage

Understanding the structure of Novavax's debt obligations provides insight if it is worth investing in it. Financial leverage can amplify the potential profits to Novavax's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its cost of debt.
Last ReportedProjected for Next Year
Net Debt-339.4 M-322.5 M
Short and Long Term Debt Total229.1 M140.8 M
Short Term Debt5.1 M4.9 M
Long Term Debt168 M114.6 M
Long Term Debt Total372 M234.9 M
Short and Long Term Debt373.6 M392.3 M
Net Debt To EBITDA 0.70  0.73 
Debt To Equity(0.23)(0.25)
Interest Debt Per Share 1.81  1.72 
Debt To Assets 0.09  0.09 
Long Term Debt To Capitalization(0.31)(0.29)
Total Debt To Capitalization(0.31)(0.32)
Debt Equity Ratio(0.23)(0.25)
Debt Ratio 0.09  0.09 
Cash Flow To Debt Ratio(4.27)(4.48)
Please read more on our technical analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novavax Stock Analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.